liver/biliary system
• mice treated with a low dose of methyleugenol fail to produce hepatic DNA adducts unlike in wild-type mice
• mice treated with 1OH-ME produce fewer hepatic DNA adducts by a factor of 120 compared to in wild-type mice
• however, cytochrome P450-mediated metabolism of methyleugenol is normal in the liver
|
cellular
• mice treated with 1-methylpyrene exhibit decreased benzylic DNA adducts in the liver and kidney compared with wild-type mice that is more severe than in Sult1d1tm1Glatt homozygotes
|
homeostasis/metabolism
• mice treated with 1-methylpyrene exhibit decreased electrophilic 1-sulfooxymethylpyrene plasma levels compared with wild-type mice
|